ResearcherKitakyushu Municipal Medical CenterActive in the last 2 years
Toru Nakano
Matched on ORCID iD 0000-0003-1824-9122; OpenAlex author ID A5044707863. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 5)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy followed by carbon-ion radiotherapy: a case … Last author DOI 10.1186/s13256-023-04311-3↗
- Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report. Last author DOI 10.1186/s40792-020-00924-8↗
- Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report. Last author DOI 10.1186/s40792-020-01070-x↗
- Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to Postoperative Adjuvant Chemotherapy. Last author DOI 10.1007/s00268-018-4496-y↗
- Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Last author DOI 10.1007/s00595-016-1426-1↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuyoshi Nishihara · 5 shared papers, 2017–2024 · strength 0.68
- Paper Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy foll… DOI 10.1186/s13256-023-04311-3↗
- Paper Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case repo… DOI 10.1186/s40792-020-00924-8↗
- Paper Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcino… DOI 10.1186/s40792-020-01070-x↗
- Tomohiko Shinkawa · 4 shared papers, 2018–2024 · strength 0.59
- Paper Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy foll… DOI 10.1186/s13256-023-04311-3↗
- Paper Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case repo… DOI 10.1186/s40792-020-00924-8↗
- Paper Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcino… DOI 10.1186/s40792-020-01070-x↗
- Yusuke Watanabe · 3 shared papers, 2017–2024 · strength 0.41
- Paper Conversion surgery for initially unresectable locally advanced pancreatic ductal adenocarcinoma after chemotherapy foll… DOI 10.1186/s13256-023-04311-3↗
- Paper Long-Term Outcomes After Pancreatectomy for Pancreatic Ductal Adenocarcinoma in Elderly Patients: Special Reference to … DOI 10.1007/s00268-018-4496-y↗
- Paper Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective re… DOI 10.1007/s00595-016-1426-1↗
- Chikanori Tsutsumi · 2 shared papers, 2020 · strength 0.27
- Paper Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case repo… DOI 10.1186/s40792-020-00924-8↗
- Paper Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcino… DOI 10.1186/s40792-020-01070-x↗
- Toshiya Abe · 2 shared papers, 2020 · strength 0.27
- Paper Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case repo… DOI 10.1186/s40792-020-00924-8↗
- Paper Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcino… DOI 10.1186/s40792-020-01070-x↗
- Kenjiro Date · 1 shared paper, 2024 · strength 0.23
- Sho Endo · 1 shared paper, 2018 · strength 0.10
- Sokichi Matsumoto · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.